Anavex Lf SC (AVXL) Stock Price, Quote & News

Company Profile

Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer . Its lead drug candidate, ANAVEX 2-73 (blarcamesine), has completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease; a Phase 2 proof-of-c...

Industry: Biotechnology

Sector: Healthcare

Phone: 844 689 3939

Website: www.anavex.com

Address:

630 5th Avenue, 20th Floor, New York, United States

Bio_Oko Feb. 6 at 8:46 PM

$AVXL great find

0 · Reply

gldncrss Feb. 6 at 8:35 PM

$AVXL so why isn’t this up more with the market breaking into new highs for the ones saying it dropped so much because the market was falling

0 · Reply

tims3667 Feb. 6 at 8:33 PM

$AVXL I sold most all my stock and still holding options. I believe the conference call that was set up for Monday morning is significant. Been wrong almost every time on this stock but there is reason to have before market open . If something big isn't announced this coming Monday will be back in mid 3's. In a market like this us longs deserve some good news.

1 · Reply

dulydiligent Feb. 6 at 8:32 PM

$AVXL 😎

0 · Reply

PharmaBro2 Feb. 6 at 7:31 PM

$AVXL partnership Monday? or EMA withdrawal monday???

1 · Reply

Greenspam Feb. 6 at 7:28 PM

$AVXL The efficacy and mechanism of sigma-1 receptor agonists as novel therapeutic agents for cardiac and renal diseases in

1 · Reply

Alexa91362 Feb. 6 at 7:23 PM

$AVXL

0 · Reply

SCLXSUX Feb. 6 at 7:10 PM

$AVXL - You gotta love some of these stock guru's who try and predict Anavex's future. Candlesticks, Downtrends, Uptrends, Stock Predictors, and my favorite, Resistance! Throw all that out the window, this is Anavex, and it will do what it wants, when it wants. Even Carnac The Magnificent would get it wrong.....Not much longer!

2 · Reply

Georgejj Feb. 6 at 7:01 PM

$AVXL https://www.anavex.com/post/anavex-life-sciences-to-announce-fiscal-2026-first-quarter-financial-results-on-monday-february-9

0 · Reply

jbrennz Feb. 6 at 6:51 PM

$AVXL Yep. This is Anavex. You gotta love it! Hold on for the ride! Continuously

0 · Reply

Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026

Jan 14, 2026, 10:15 PM EST - 22 days ago

Anavex Life Sciences Corp. (AVXL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 7:30 AM EST - 24 days ago

Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer's Disease

Jan 8, 2026, 7:30 AM EST - 4 weeks ago

Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology

Jan 6, 2026, 7:30 AM EST - 4 weeks ago

Anavex Life Sciences Receives FDA Feedback on Alzheimer's Disease Program

Dec 24, 2025, 10:30 AM EST - 6 weeks ago

AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

Dec 18, 2025, 7:30 AM EST - 7 weeks ago

Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion

Dec 12, 2025, 4:05 PM EST - 7 weeks ago

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer's Disease

Nov 26, 2025, 7:30 AM EST - 2 months ago

Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference

Nov 25, 2025, 11:53 AM EST - 2 months ago

Anavex Life Sciences Corp. (AVXL) Q4 2025 Earnings Call Transcript

Nov 25, 2025, 7:30 AM EST - 2 months ago

Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update

Nov 19, 2025, 7:30 AM EST - 2 months ago

Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference

Nov 18, 2025, 7:30 AM EST - 2 months ago

Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025

Nov 14, 2025, 7:30 AM EST - 3 months ago

Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease

Oct 29, 2025, 7:30 AM EDT - 3 months ago

Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Control Group

Oct 10, 2025, 7:30 AM EDT - 4 months ago

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care'

Oct 2, 2025, 1:40 PM EDT - 4 months ago

Anavex: ANAVEX 3-71 Could Potentially Offer Disease-Modifying Effects For Schizophrenia

Oct 2, 2025, 7:35 AM EDT - 4 months ago

Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program

Oct 2, 2025, 7:30 AM EDT - 4 months ago

Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

Sep 30, 2025, 8:30 AM EDT - 4 months ago

Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer's Disease Trial

Sep 9, 2025, 7:30 AM EDT - 5 months ago

Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer's Disease Trial

Sep 2, 2025, 7:30 AM EDT - 5 months ago

Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025

Aug 26, 2025, 7:30 AM EDT - 5 months ago

Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine

Aug 20, 2025, 7:30 AM EDT - 6 months ago

Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer's Disease

Aug 12, 2025, 10:38 AM EDT - 6 months ago

Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call Transcript

Aug 12, 2025, 7:30 AM EDT - 6 months ago

Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update

Aug 5, 2025, 7:30 AM EDT - 6 months ago

Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025

Jul 31, 2025, 7:30 AM EDT - 6 months ago

Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease

May 15, 2025, 8:49 PM EDT - 9 months ago

Does Anavex's Alzheimer's Drug Actually Confer Benefit?

May 15, 2025, 12:21 PM EDT - 9 months ago

The Unusual Effects Of Anavex's Blarcamesine On Alzheimer's Disease (Upgrade)

May 14, 2025, 7:30 AM EDT - 9 months ago

Anavex Life Sciences to Participate at Upcoming Healthcare Conferences

May 13, 2025, 9:25 AM EDT - 9 months ago

Anavex Life Sciences Corp. (AVXL) Q2 2025 Earnings Call Transcript

May 13, 2025, 7:30 AM EDT - 9 months ago

Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update

May 6, 2025, 7:30 AM EDT - 9 months ago

Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025

May 1, 2025, 7:30 AM EDT - 10 months ago

Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

Apr 30, 2025, 7:30 AM EDT - 10 months ago

Anavex Life Sciences to Participate in The Citizens Life Sciences Conference

Apr 23, 2025, 7:30 AM EDT - 10 months ago

Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board

Apr 21, 2025, 7:30 AM EDT - 10 months ago

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer's Disease and Related Disorders in the Middle East

Apr 5, 2025, 11:30 AM EDT - 10 months ago

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease

Mar 31, 2025, 7:30 AM EDT - 11 months ago

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference

Feb 24, 2025, 7:30 AM EST - 1 year ago

Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference

Feb 14, 2025, 6:02 PM EST - 1 year ago

Anavex: Looking At Different Statistical Approaches Before EMA Opinion

Feb 12, 2025, 3:13 PM EST - 1 year ago

Anavex: Further Validation Of Blarcamesine With Schizophrenia Data In 2025

Feb 12, 2025, 9:59 AM EST - 1 year ago

Anavex Life Sciences Corp. (AVXL) Q1 2025 Earnings Call Transcript

Feb 12, 2025, 7:30 AM EST - 1 year ago

Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update

Feb 5, 2025, 7:30 AM EST - 1 year ago

Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025

Jan 27, 2025, 7:30 AM EST - 1 year ago

Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio

Bio_Oko Feb. 6 at 8:46 PM

$AVXL great find

0 · Reply

gldncrss Feb. 6 at 8:35 PM

$AVXL so why isn’t this up more with the market breaking into new highs for the ones saying it dropped so much because the market was falling

0 · Reply

tims3667 Feb. 6 at 8:33 PM

1 · Reply

dulydiligent Feb. 6 at 8:32 PM

$AVXL 😎

0 · Reply

PharmaBro2 Feb. 6 at 7:31 PM

$AVXL partnership Monday? or EMA withdrawal monday???

1 · Reply

Greenspam Feb. 6 at 7:28 PM

$AVXL The efficacy and mechanism of sigma-1 receptor agonists as novel therapeutic agents for cardiac and renal diseases in

1 · Reply

Alexa91362 Feb. 6 at 7:23 PM

$AVXL

0 · Reply

SCLXSUX Feb. 6 at 7:10 PM

2 · Reply

Georgejj Feb. 6 at 7:01 PM

$AVXL https://www.anavex.com/post/anavex-life-sciences-to-announce-fiscal-2026-first-quarter-financial-results-on-monday-february-9

0 · Reply

jbrennz Feb. 6 at 6:51 PM

$AVXL Yep. This is Anavex. You gotta love it! Hold on for the ride! Continuously

0 · Reply

Lilac Feb. 6 at 6:49 PM

$AVXL ♥️

0 · Reply

Georgejj Feb. 6 at 6:38 PM

$AVXL There should be a lot of financial institutions buying AVXL stock just prior to the close of trading today in anticipation of news this coming Monday!!!

1 · Reply

PharmaBro2 Feb. 6 at 6:27 PM

$AVXL Monday we see $2

1 · Reply

gldncrss Feb. 6 at 6:26 PM

$AVXL looks like it might squeeze some

1 · Reply

Georgejj Feb. 6 at 6:25 PM

$AVXL Today there could be well over 1.5 million shares of AVXL stock bought and possibly much much more in anticipation of news on Monday!!! Good luck and GOD bless,

0 · Reply

tobeme100 Feb. 6 at 6:08 PM

$AVXL Wolfgang is so active on LinkedIn. He must have lots of time...

1 · Reply

Rock6Times Feb. 6 at 6:05 PM

$AVXL 420? Light it up!

0 · Reply

NorvaK Feb. 6 at 5:57 PM

$AVXL $4.20

0 · Reply

papatrick Feb. 6 at 5:57 PM

$AVXL Yea...shorts covering a little to produce a better crash when Missling takes the mic, as usual! Let's sell today and buy back Monday in the low 3!

1 · Reply

DrocDolf Feb. 6 at 5:53 PM

$AVXL tick tock tick tock 🕰️⚰️

0 · Reply

old_salt Feb. 6 at 5:52 PM

$AVXL 💪 let's go!

0 · Reply

Stoneage823 Feb. 6 at 5:35 PM

$AVXL normal sp 10-12$… might be last chance at basically buy one get two free at these prices

0 · Reply

Market Cap	369.01M
Revenue (ttm)	0.00
Net Income (ttm)	-46.38M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,004,073
Avg Vol	2,101,952
Day's Range	N/A - N/A
Shares Out	89.35M
Stochastic %K	0%
Beta	1.21
Analysts	Sell
Price Target	$22.00